{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:43Z","timestamp":1790633383840,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068616"],"award-info":[{"award-number":["UM1AI068616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI106716"],"award-info":[{"award-number":["UM1AI106716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/jac\/dky567","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T21:42:16Z","timestamp":1545082936000},"page":"1348-1356","source":"Crossref","is-referenced-by-count":14,"title":["Evaluating darunavir\/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling"],"prefix":"10.1093","volume":"74","author":[{"given":"Stein","family":"Schalkwijk","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud university medical center, Nijmegen, The Netherlands"},{"name":"Department of Pharmacology & Toxicology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"ter Heine","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Colbers","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Capparelli","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences & School of Medicine, University of California San Diego, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brookie M","family":"Best","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences & School of Medicine, University of California San Diego, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim R","family":"Cressey","sequence":"additional","affiliation":[{"name":"Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand"},{"name":"Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G M","family":"Russel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Lluita contra la Sida, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"},{"name":"Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona (UAB), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mirochnick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats O","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud university medical center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"2019042309340411500_dky567-B1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/phar.1626","article-title":"Antiretroviral pharmacokinetics in pregnant women","volume":"35","author":"Gilbert","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2019042309340411500_dky567-B2","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ajog.2007.03.081","article-title":"Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999\u20132001","volume":"197","author":"Harris","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2019042309340411500_dky567-B3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000\u20132011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"key":"2019042309340411500_dky567-B4"},{"key":"2019042309340411500_dky567-B5"},{"key":"2019042309340411500_dky567-B6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/hiv.12047","article-title":"Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir\/ritonavir 600\/100 mg administered twice daily","volume":"15","author":"Zorrilla","year":"2014","journal-title":"HIV Med"},{"key":"2019042309340411500_dky567-B7","author":"Courbon"},{"key":"2019042309340411500_dky567-B8","author":"Curran"},{"key":"2019042309340411500_dky567-B9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dku400","article-title":"Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women","volume":"70","author":"Colbers","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019042309340411500_dky567-B10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/QAI.0000000000000668","article-title":"Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women","volume":"70","author":"Stek","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019042309340411500_dky567-B11","first-page":"16","article-title":"Pharmacokinetics and safety of darunavir\/ritonavir in HIV-infected pregnant women","volume":"19","author":"Khoo","year":"2017","journal-title":"AIDS Rev"},{"key":"2019042309340411500_dky567-B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1468-1293.2012.01030.x","article-title":"British HIV Association guidelines for the management of HIV infection in pregnant women 2012","volume":"13","author":"Taylor","year":"2012","journal-title":"HIV Med"},{"key":"2019042309340411500_dky567-B13","author":"Stek"},{"key":"2019042309340411500_dky567-B14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40262-013-0057-6","article-title":"Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients","volume":"52","author":"Molt\u00f3","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"2019042309340411500_dky567-B15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"2019042309340411500_dky567-B16","year":"2006"},{"key":"2019042309340411500_dky567-B17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1124\/dmd.112.044677","article-title":"Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice","volume":"40","author":"Holmstock","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"2019042309340411500_dky567-B18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40262-015-0325-8","article-title":"Physiologically based modelling of darunavir\/ritonavir pharmacokinetics during pregnancy","volume":"55","author":"Colbers","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"2019042309340411500_dky567-B19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","article-title":"Handling data below the limit of quantification in mixed effect models","volume":"11","author":"Bergstrand","year":"2009","journal-title":"AAPS J"},{"key":"2019042309340411500_dky567-B20","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/jac\/dku131","article-title":"Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals","volume":"69","author":"Arab-Alameddine","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2019042309340411500_dky567-B21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10928-016-9487-8","article-title":"Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling","volume":"43","author":"Dosne","year":"2016","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2019042309340411500_dky567-B22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2125.2012.04205.x","article-title":"Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics","volume":"74","author":"Svensson","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"2019042309340411500_dky567-B23","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.42.11.2784","article-title":"Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers","volume":"42","author":"Hsu","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309340411500_dky567-B24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/AAC.41.5.898","article-title":"Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects","volume":"41","author":"Hsu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309340411500_dky567-B25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","article-title":"Pira\u00f1a and PCluster: a modeling environment and cluster infrastructure for NONMEM","volume":"101","author":"Keizer","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"key":"2019042309340411500_dky567-B26","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2019042309340411500_dky567-B27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1128\/AAC.49.6.2314-2321.2005","article-title":"TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates","volume":"49","author":"De Meyer","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309340411500_dky567-B28","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/bcp.13432","article-title":"Free dug concentrations in pregnancy: bound to measure unbound?","volume":"83","author":"Schalkwijk","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2019042309340411500_dky567-B29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2019042309340411500_dky567-B30","volume-title":"Abstracts of the Seventeenth International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, Washington, DC, USA, 2016","author":"Colbers"},{"key":"2019042309340411500_dky567-B31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200847100-00005","article-title":"Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults","volume":"47","author":"Molt\u00f3","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"2019042309340411500_dky567-B32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.104.075416","article-title":"Mechanism-based inactivation of CYP3A by HIV protease inhibitors","volume":"312","author":"Ernest","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2019042309340411500_dky567-B33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/dmd.108.024109","article-title":"Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects","volume":"37","author":"Vermeir","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"2019042309340411500_dky567-B34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QAI.0b013e31827fd47e","article-title":"Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines","volume":"63","author":"Patterson","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019042309340411500_dky567-B35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","article-title":"Gestation-specific changes in the anatomy and physiology of healthy pregnant women: an extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/5\/1348\/28501273\/dky567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T09:37:49Z","timestamp":1556012269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/5\/1348\/5304685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,1,30]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky567","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,1,30]]}}}